Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Unity Biotechnology, Inc. (UBX)
|
Add to portfolio |
|
|
|
| Price: |
$1.86
| | Metrics |
| OS: |
14.6
|
M
| |
-100
|
% ROE
|
| Market cap: |
$27.2
|
M
| |
|
|
|
Net cash:
|
$19.1
|
M
| |
$1.31
|
per share
|
|
EV:
|
$8.04
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($3.94)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 0.2 | 36.9 | 4.8 | 38.4 | 0.0 | 0.0 | 0.0 | 1.4 |
| Revenue growth | -95.1% | -4.0% | | | | | -100.0% | |
| Cost of goods sold | 0.0 | 57.8 | 0.0 | 61.4 | 0.0 | -91.0 | 0.0 | 0.0 |
| Gross profit | 0.2 | -20.9 | 4.8 | -23.1 | 0.0 | 91.0 | 0.0 | 1.4 |
| Gross margin | 100.0% | -56.8% | 100.0% | -60.1% | | | | 100.0% |
| Selling, general and administrative | 57.8 | | 61.4 | | 93.9 | | | |
| Research and development | | | | | | 71.0 | 58.9 | 37.4 |
| General and administrative | | 20.9 | | 23.1 | | 20.0 | 16.0 | 9.6 |
| EBIT | -57.6 | -57.6 | -56.7 | -56.7 | -93.9 | -91.0 | -74.9 | -45.6 |
| EBIT margin | -24394.9% | -156.2% | -1184.5% | -147.6% | | | | -3300.1% |
| Pre-tax income | -59.9 | -59.9 | -60.7 | -60.7 | -93.8 | -82.2 | -76.4 | -44.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -59.9 | -59.9 | -60.7 | -60.7 | -93.8 | -82.2 | -76.4 | -44.7 |
| Net margin | -25392.8% | -162.6% | -1269.3% | -158.2% | | | | -3231.3% |
| |
| Diluted EPS | ($6.31) | ($6.31) | ($10.88) | ($10.88) | ($18.45) | ($1.88) | ($2.70) | ($13.97) |
| Shares outstanding (diluted) | 9.5 | 9.5 | 5.6 | 5.6 | 5.1 | 43.6 | 28.3 | 3.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|